ORIX stock has delivered a very strong 309.8% return over the past five years, yet the current valuation checks suggest the market price may still sit well below an intrinsic value estimate based on the Excess Returns model and supported by earnings multiples.
- Over five years, ORIX has returned 309.8%, which puts the recent share price level in sharp focus for anyone wondering how much of the story is already reflected in the valuation.
- The key support for the current valuation is that ORIX can continue to convert its diversified financial operations into steady cash generation. A central risk is that any pressure on asset quality or funding costs could strain those cash flows and compress what appears to be a discount.
- On Simply Wall St's broader checks, ORIX is assessed as undervalued in 3 of 6 tests. This is a mixed picture rather than a clear bargain or clear overvaluation, which you can see in more detail at 3/6 value score.
The issue now is whether ORIX's strong share price record and the current discount suggested by the intrinsic value estimate still leave a comfortable margin between market price and long term value.
Is ORIX Still Cheap on Excess Returns?
The Excess Returns model starts by looking at how efficiently ORIX turns its equity base into earnings above the required investor return. Here, the inputs point to stable earnings power of ¥544.10 per share on a stable book value of ¥4,815.38 per share, with an average Return on Equity of 11.30%. Against a cost of equity of ¥240.59 per share, that leaves an excess return of ¥303.52 per share. This suggests that ORIX is expected to generate returns above its hurdle rate rather than just covering its capital cost.
When those excess returns are projected forward and added to the current book value of ¥4,080.24 per share, the Excess Returns model arrives at an intrinsic value of about ¥12,048 per share. Compared with the current share price, this implies a 45.8% discount, which is consistent with the model view that the stock is undervalued, even after the strong share price performance already seen from ORIX.
On these Excess Returns assumptions, ORIX screens as undervalued, with the model indicating a wide gap between intrinsic value and the current market price.
Our Excess Returns analysis suggests ORIX is undervalued by 45.8%. Track this in your watchlist or portfolio, or discover 17 more high quality undervalued stocks.
Is ORIX a Bargain on Earnings?
The P/E ratio is a useful way to look at ORIX because earnings are a central focus for a diversified financial group. ORIX currently trades on a P/E of about 16.0x, compared with a Diversified Financial industry average of roughly 14.2x and a peer group average of about 14.0x. On simple comparisons, the stock carries a modest premium to its sector and peers.
However, a more tailored fair P/E ratio for ORIX, which considers factors such as its growth profile, margins, size and risk, is estimated at about 18.1x. Against this benchmark, the current 16.0x multiple sits at a discount, indicating that the market price is below the level implied by this framework for its earnings power.
On this P/E measure, ORIX stock appears undervalued relative to the fair multiple suggested by this model.
See what the numbers say about this price — find out in our valuation breakdown.
The ORIX Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for ORIX pick up where this valuation puzzle leaves off. They spell out which combinations of future growth, margins and earnings would need to hold for the stock to be worth materially more or less than today’s price, and they sit on the company’s Community page. Each narrative treats fair value as a thesis about ORIX's business that you can track over time rather than a single static number.
One of the top community narratives on ORIX: roughly fairly valued
"ORIX's ongoing capital recycling strategy, highlighted by portfolio optimization through divesting non-core assets and reallocating proceeds into higher-growth areas like green energy and private asset management, is expected to drive higher ROE and long-term net income growth."
Read one of the top narratives on ORIX
Do you think there's more to the story for ORIX? Head over to our Community to see what others are saying!
The Bottom Line
For ORIX, both the Excess Returns intrinsic value estimate and the earnings multiple work point in the same direction, suggesting the stock is undervalued despite a mixed broader set of checks. The intrinsic value framework implies a wide discount, while the tailored P/E view also indicates the current multiple sits below what its earnings profile might justify. The key issue from here is whether ORIX can keep turning its diversified financial operations into resilient returns on equity, without asset quality or funding pressures eroding the apparent valuation gap and turning the discount into a value trap.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com